Corbus Pharmaceuticals Holdings CRBP
NASDAQ CRBP
$4.13 -0.15 (-3.50%)
At close: Oct 22, 2026 · 4:00 PM EDT

Corbus Pharmaceuticals Holdings (CRBP) Depreciation & Amortization (CF) (2014 - 2025)

Updated

Corbus Pharmaceuticals Holdings' Depreciation & Amortization (CF) came in at $50,000 for Q3 2025, down 67.1% from $152,000 a year earlier and down 5.7% from the prior quarter.

Analysis

Corbus Pharmaceuticals Holdings (CRBP) Depreciation & Amortization (CF) (2014 - 2025) Analysis & Trends

Over the trailing twelve months to Sep 30, 2025, Corbus Pharmaceuticals Holdings reported Depreciation & Amortization (CF) of $318,000, down 47.2% year-over-year; for FY2024, it came in at $588,000, down 8.3% from FY2023.

  • Depreciation & Amortization (CF) has declined in each of the last four years, with a five-year compound annual growth rate of -4.5% (FY2019 to FY2024).
  • Going back by year, Depreciation & Amortization (CF) was $641,000 in FY2023 (-16.0%), $762,995 in FY2022 (-23.7%), $999,817 in FY2021 (-11.0%) and $1.12 million in FY2020 (+52.0%).
  • The Q3 2025 figure represents the lowest quarterly Depreciation & Amortization (CF) since Q2 2017.
  • Year-over-year, Depreciation & Amortization (CF) has declined for 16 consecutive quarters, with an average decline of 28.7% over the last eight quarters.
  • The fastest year-over-year change in Depreciation & Amortization (CF) over five years came in Q3 2021 (growth of 26.8%), and the weakest in Q3 2025 (a decline of 67.1%).
  • Business Quant data shows CRBP's Depreciation & Amortization (CF) at $53,000 (Q2 2025), $81,000 (Q1 2025) and $134,000 (Q4 2024) in the three quarters before Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 2.12 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 194.00 Mn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn -
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 1.93 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 98.00 Mn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 1.62 Bn
10 Corbus Pharmaceuticals Holdings 51.77 Mn -464.86 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 50,000.00
Jun 30, 2025 53,000.00
Mar 31, 2025 81,000.00
Dec 31, 2024 134,000.00
Sep 30, 2024 152,000.00
Jun 30, 2024 150,000.00
Mar 31, 2024 152,000.00
Dec 31, 2023 148,000.00
Sep 30, 2023 153,000.00
Jun 30, 2023 158,130.00
Mar 31, 2023 181,870.00
Dec 31, 2022 184,397.00
Sep 30, 2022 190,795.00
Jun 30, 2022 192,084.00
Mar 31, 2022 195,719.00
Dec 31, 2021 207,685.00
Sep 30, 2021 256,286.00
Jun 30, 2021 263,660.00
Mar 31, 2021 272,186.00
Dec 31, 2020 282,099.00
API Access

Corbus Pharmaceuticals Holdings Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=CRBP&period=max&api_key=YOUR_API_KEY